12:00 AM
Apr 26, 2010
 |  BC Week In Review  |  Company News  |  Deals

Oriel Therapeutics Inc., Novartis deal

Novartis' generics unit, Sandoz International GmbH, acquired Oriel for an undisclosed amount. Oriel develops generics for asthma...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >